AFFYMETRIX INC
10-Q, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: AFFYMETRIX INC, 10-Q, 2000-11-14
Next: RENAISSANCERE HOLDINGS LTD, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ITEM 1 OF
THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           3,770
<SECURITIES>                                   425,292
<RECEIVABLES>                                   47,697
<ALLOWANCES>                                   (1,559)
<INVENTORY>                                     17,599
<CURRENT-ASSETS>                               497,251
<PP&E>                                          77,169
<DEPRECIATION>                                (24,439)
<TOTAL-ASSETS>                                 609,283
<CURRENT-LIABILITIES>                           61,229
<BONDS>                                        375,000
                                0
                                          0
<COMMON>                                           555
<OTHER-SE>                                     164,499
<TOTAL-LIABILITY-AND-EQUITY>                   609,283
<SALES>                                        122,227
<TOTAL-REVENUES>                               141,411
<CGS>                                           49,117
<TOTAL-COSTS>                                   49,117
<OTHER-EXPENSES>                               109,619
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              13,597
<INCOME-PRETAX>                               (12,066)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (12,066)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (12,066)
<EPS-BASIC>                                     (0.22)
<EPS-DILUTED>                                   (0.22)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission